	Capitaux D'Emprunt		Date
Alaunos Therapeutics	USD 4.47M	5.85M	2022-06
Alnylam Pharmaceuticals	USD 2.48B	1.44B	2025-12
Alterity Therapeutics Limited	AUD 103.21K	73.88K	2023-06
Amgen	USD 50B	2.43B	2025-12
Bayer	EUR 32.71B	1B	2025-09
BioCryst Pharmaceuticals	USD 194.37M	48.43M	2025-09
Biogen	USD 6.29B	1.4M	2025-09
BioMarin Pharmaceutical	USD 597.18M	513K	2025-12
Cipla	INR 2.98B	454.6M	2025-09
Clal Biotechnology	ILS 25.96M	18.48M	2023-12
Compugen	USD 0	0	2024-12
CSL	USD 10.42B	273M	2025-12
Gilead Sciences	USD 22.14B	5M	2025-09
GlaxoSmithKline	GBP 14.71B	186M	2025-12
Grifols	EUR 10.67B	564.4M	2025-09
Ionis Pharmaceuticals	USD 1.9B	1.87B	2025-12
J&J	USD 39.44B	30M	2025-12
Karyopharm Therapeutics	USD -0.93	0.67	2024-12
Merck	USD 39.97B	6B	2025-09
Novartis	USD 24.24B	174M	2025-09
Omeros	USD 403.72M	27.2M	2024-06
Pfizer	USD 57.41B	93M	2025-09
Roche Holding	CHF 27.43B	966M	2025-12
Sangamo BioSciences	USD 0	0	2022-06
Sanofi	EUR 15.72B	2.45B	2025-12
Sarepta Therapeutics	USD 828.97M	206.17M	2025-12
Tectonic Therapeutic	USD 100K	86K	2025-09
Ultragenyx Pharmaceutical	USD 763.74M	19.02M	2025-09
Vertex Pharmaceuticals	USD 111.4M	1.4M	2025-03

Sangamo BioSciences Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.